Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Patrick Mangialardi, Richart Harper & Timothy E Albertson. (2022) The pharmacotherapeutics of sarcoidosis. Expert Review of Clinical Pharmacology 15:1, pages 51-64.
Read now
Read now
Wa Nienhuis & Jc Grutters. (2022) Potential therapeutic targets to prevent organ damage in chronic pulmonary sarcoidosis. Expert Opinion on Therapeutic Targets 26:1, pages 41-55.
Read now
Read now
Parnia Jabbari, Mona Sadeghalvad & Nima Rezaei. (2021) An inflammatory triangle in Sarcoidosis: PPAR-γ, immune microenvironment, and inflammation. Expert Opinion on Biological Therapy 21:11, pages 1451-1459.
Read now
Read now
Articles from other publishers (14)
Rui Wang, Siyi Zhang, Yifei Liu, Hongmei Li, Suzhen Guan, Lingqin Zhu, Leina Jia, Zhihong Liu & Haiming Xu. (2024) The role of macrophage polarization and related key molecules in pulmonary inflammation and fibrosis induced by coal dust dynamic inhalation exposure in Sprague-Dawley rats. Cytokine 173, pages 156419.
Crossref
Crossref
Raluca Ioana Arcana, Radu Crișan-Dabija, Andrei Tudor Cernomaz, Ioana Buculei, Alexandru Burlacu, Mihai Lucian Zabară & Antigona Carmen Trofor. (2023) The Risk of Sarcoidosis Misdiagnosis and the Harmful Effect of Corticosteroids When the Disease Picture Is Incomplete. Biomedicines 11:1, pages 175.
Crossref
Crossref
Yoshinori Kawabata. 2023. Tuberculosis. Tuberculosis
1003
1031
.
Zhaoqiang Zhang, Xiao Wu, Guizhi Han, Bo Shao, Li Lin & Shunli Jiang. (2022) Altered M1/M2 polarization of alveolar macrophages is involved in the pathological responses of acute silicosis in rats in vivo. Toxicology and Industrial Health 38:12, pages 810-818.
Crossref
Crossref
Anna Malkova, Yulia Zinchenko, Anna Starshinova, Dmitriy Kudlay, Igor Kudryavtsev, Anzhela Glushkova, Piotr Yablonskiy & Yehuda Shoenfeld. (2022) Sarcoidosis: Progression to the chronic stage and pathogenic based treatment (narrative review). Frontiers in Medicine 9.
Crossref
Crossref
Entezar Mehrabi Nasab & Seyyed Shamsadin Athari. 2022. Sarcoidosis - New Perspectives. Sarcoidosis - New Perspectives.
Julie H. Wu, Sotonye Imadojemu & Avrom S. Caplan. (2022) The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy. American Journal of Clinical Dermatology 23:4, pages 499-514.
Crossref
Crossref
I. E. Malysheva, E. L. Tikhonovich, E. K. Oleinik, L. V. Topchieva & O. V. Balan. (2021) Macrophage polarization in sarcoidosis. Medical Immunology (Russia) 23:1, pages 7-16.
Crossref
Crossref
Tucker v R. Burr & João F. Kazan-Tannus. (2021) Myositis and myopathy of sarcoidosis: A case report. Radiology Case Reports 16:3, pages 433-437.
Crossref
Crossref
Avrom Caplan, Misha Rosenbach & Sotonye Imadojemu. (2020) Cutaneous Sarcoidosis. Seminars in Respiratory and Critical Care Medicine 41:05, pages 689-699.
Crossref
Crossref
Francesca Polverino, Elisabetta Balestro & Paolo Spagnolo. (2020) Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art. Journal of Clinical Medicine 9:8, pages 2363.
Crossref
Crossref
Ian McClain Caldwell, Christopher Hogden, Krisztian Nemeth, Michael Boyajian, Miklos Krepuska, Gergely Szombath, Sandra MacDonald, Mehrnoosh Abshari, Joel Moss, Lynn Vitale-Cross, Joseph R Fontana & Eva Mezey. (2020) Bone Marrow-Derived Mesenchymal Stromal Cells (MSCs) Modulate the Inflammatory Character of Alveolar Macrophages from Sarcoidosis Patients. Journal of Clinical Medicine 9:1, pages 278.
Crossref
Crossref
А. А. VIZEL & I. YU. VIZEL. (2019) LEFLUNOMIDE AS A POTENTIAL SECOND-LINE DRUG IN THE TREATMENT OF SARCOIDOSIS. TUBERCULOSIS AND LUNG DISEASES 97:8, pages 52-58.
Crossref
Crossref
Marc A Judson. (2019) Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns. F1000Research 8, pages 2149.
Crossref
Crossref